UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034305
Receipt number R000039096
Scientific Title Effective use of Drinking-Ultrasonography for the diagnosis of Helicobacter pylori-associated dyspepsia
Date of disclosure of the study information 2018/10/01
Last modified on 2018/09/27 14:55:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effective use of Drinking-Ultrasonography for the diagnosis of Helicobacter pylori-associated dyspepsia

Acronym

Drinking-Ultrasonography for Helicobacter pylori-associated dyspepsia

Scientific Title

Effective use of Drinking-Ultrasonography for the diagnosis of Helicobacter pylori-associated dyspepsia

Scientific Title:Acronym

Drinking-Ultrasonography for Helicobacter pylori-associated dyspepsia

Region

Japan


Condition

Condition

Helicobacter pylori-associated dyspepsia

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate whether Drinking-Ultrasonography Test is effective for the early diagnose of Helicobacter pylori-associated dyspepsia

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Calculate the correct diagnosis rate of Helicobacter pylori-associated dyspepsia with sensory hypersensitivity by Drinking-Ultrasonography Test at 2 months, 6 months to 1 year after eradication

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

1)Persons whose age is 20 years or older at the time of acquiring consent
2)Helicobacter pylori infected patients
3)The patients who will perform eradication therapy
4)Persons who have recorded GSRS (Gastrointestinal Symptom Rating Scale) and GOS (Global Overall Severity) that evaluate abdominal symptoms before eradication
5)The patients who will perform upper gastointestinal endoscopy before eradication
6)The patients who will perform Drinking-Ultrasonograhy Tet before eradication
7)Patients from whom written informed consent is obtained.

Key exclusion criteria

1)The patients who have allergic to eradication drugs
2)The patients with organic disease in the stomach
3)Patients who are judged as being inappropriate for this study by their medical doctor

Target sample size

48


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shoko Ono

Organization

Hokkaido University Hospital

Division name

Division of Gastroenterology and Hepatology

Zip code


Address

Kita 14, Nishi 5, Kita-ku, Sapporo

TEL

011-716-1161

Email

onosho@med.hokudai.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Momoko Tsuda

Organization

Hokkaido University Hospital

Division name

Division of Gastroenterology and Hepatology

Zip code


Address

Kita 14, Nishi 5, Kita-ku, Sapporo

TEL

011-716-1161

Homepage URL


Email

momoko0221tsuda@gmail.com


Sponsor or person

Institute

Hokkaido University

Institute

Department

Personal name



Funding Source

Organization

Self-sourcing

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2018 Year 08 Month 27 Day

Date of IRB


Anticipated trial start date

2018 Year 08 Month 27 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Exploratory prospective study to conduct Drinking-Ultrasonography Test before and after eradication


Management information

Registered date

2018 Year 09 Month 28 Day

Last modified on

2018 Year 09 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039096


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name